Literature DB >> 26390213

Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug Solubilization.

Maya P Lipert1, Lilly Roy1, Scott L Childs2, Naír Rodríguez-Hornedo3.   

Abstract

This work examines cocrystal solubility in biorelevant media (FeSSIF, fed-state simulated intestinal fluid), and develops a theoretical framework that allows for the simple and quantitative prediction of cocrystal solubilization from drug solubilization. The solubilities of four hydrophobic drugs and seven cocrystals containing these drugs were measured in FeSSIF and in acetate buffer at pH 5.00. In all cases, the cocrystal solubility (Scocrystal ) was higher than the drug solubility (Sdrug ) in both buffer and FeSSIF; however, the solubilization ratio of drug, SRdrug = (SFeSSIF /Sbuffer )drug , was not the same as the solubilization ratio of cocrystal, SRcocrystal = (SFeSSIF /Sbuffer )cocrystal , meaning drug and cocrystal were not solubilized to the same extent in FeSSIF. This highlights the potential risk of anticipating cocrystal behavior in biorelevant media based on solubility studies in water. Predictions of SRcocrystal from simple equations based only on SRdrug were in excellent agreement with measured values. For 1:1 cocrystals, the cocrystal solubilization ratio (SR) can be obtained from the square root of the drug SR. For 2:1 cocrystals, SRcocrystal is found from (SRdrug )(2/3) . The findings in FeSSIF can be generalized to describe cocrystal behavior in other systems involving preferential solubilization of a drug such as surfactants, lipids, and other drug solubilizing media.
© 2015 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  cocrystals; food effects; mathematical model; oral absorption; physicochemical properties; poorly water-soluble drugs; preformulation; solubility; supersaturation; surfactants

Mesh:

Substances:

Year:  2015        PMID: 26390213      PMCID: PMC4706795          DOI: 10.1002/jps.24640

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  21 in total

1.  Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media.

Authors:  Edmund S Kostewicz; Ulrich Brauns; Robert Becker; Jennifer B Dressman
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

2.  Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.

Authors:  Neal Huang; Naír Rodríguez-Hornedo
Journal:  J Pharm Sci       Date:  2011-09-09       Impact factor: 3.534

Review 3.  The effects of food on drug bioavailability.

Authors:  P A Winstanley; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

4.  Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profiles.

Authors:  W N Charman; M C Rogge; A W Boddy; W H Barr; B M Berger
Journal:  J Clin Pharmacol       Date:  1993-12       Impact factor: 3.126

5.  Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions.

Authors:  K G Mooney; M A Mintun; K J Himmelstein; V J Stella
Journal:  J Pharm Sci       Date:  1981-01       Impact factor: 3.534

6.  Cocrystals of quercetin with improved solubility and oral bioavailability.

Authors:  Adam J Smith; Padmini Kavuru; Lukasz Wojtas; Michael J Zaworotko; R Douglas Shytle
Journal:  Mol Pharm       Date:  2011-08-25       Impact factor: 4.939

7.  Cocrystal Transition Points: Role of Cocrystal Solubility, Drug Solubility, and Solubilizing Agents.

Authors:  Maya P Lipert; Naír Rodríguez-Hornedo
Journal:  Mol Pharm       Date:  2015-08-28       Impact factor: 4.939

8.  Contribution to the understanding of oxicam ionization constants.

Authors:  E Bernhard; F Zimmermann
Journal:  Arzneimittelforschung       Date:  1984

9.  pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.

Authors:  Amjad Alhalaweh; Lilly Roy; Naír Rodríguez-Hornedo; Sitaram P Velaga
Journal:  Mol Pharm       Date:  2012-08-23       Impact factor: 4.939

10.  Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.

Authors:  Rachel Courtney; David Wexler; Elaine Radwanski; Josephine Lim; Mark Laughlin
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

View more
  7 in total

Review 1.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

2.  Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2018-02-02       Impact factor: 4.200

Review 3.  Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.

Authors:  Gislaine Kuminek; Fengjuan Cao; Alanny Bahia de Oliveira da Rocha; Simone Gonçalves Cardoso; Naír Rodríguez-Hornedo
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

4.  How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability.

Authors:  G Kuminek; N Rodríguez-Hornedo; S Siedler; H V A Rocha; S L Cuffini; S G Cardoso
Journal:  Chem Commun (Camb)       Date:  2016-04-04       Impact factor: 6.222

5.  Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation.

Authors:  Hakyeong Kim; Soeun Jang; Il Won Kim
Journal:  Pharmaceutics       Date:  2021-04-25       Impact factor: 6.321

Review 6.  Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.

Authors:  Isabela Fanelli Barreto Biscaia; Samantha Nascimento Gomes; Larissa Sakis Bernardi; Paulo Renato Oliveira
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

7.  Eutectic Formation of Naproxen with Some Dicarboxylic Acids.

Authors:  Dahye Kim; Soeun Jang; Il Won Kim
Journal:  Pharmaceutics       Date:  2021-12-04       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.